BDBM498041 US11008314, Compound 125

SMILES CN(C)Cc1cccc(c1)C(=O)Nc1ncc(Sc2cc(C(=O)N3CCN([C@@H](C3)C#N)C(=O)C=C)c(C)cc2C)s1

InChI Key InChIKey=BZFYUACVFWMJMG-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 498041   

TargetTyrosine-protein kinase JAK3(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498041(US11008314, Compound 125)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498041(US11008314, Compound 125)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498041(US11008314, Compound 125)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498041(US11008314, Compound 125)
Affinity DataIC50: 55nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent